0001962918-24-000002.txt : 20240104 0001962918-24-000002.hdr.sgml : 20240104 20240104180903 ACCESSION NUMBER: 0001962918-24-000002 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240102 FILED AS OF DATE: 20240104 DATE AS OF CHANGE: 20240104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lin Shao-Lee CENTRAL INDEX KEY: 0001725092 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41696 FILM NUMBER: 24513667 MAIL ADDRESS: STREET 1: C/O ACELYRIN, INC. STREET 2: 4149 LIBERTY CANYON RD. CITY: AGOURA HILLS STATE: CA ZIP: 91301 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACELYRIN, Inc. CENTRAL INDEX KEY: 0001962918 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 852406735 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4149 LIBERTY CANYON RD. CITY: AGOURA HILLS STATE: CA ZIP: 91301 BUSINESS PHONE: 805-871-4300 MAIL ADDRESS: STREET 1: 4149 LIBERTY CANYON RD. CITY: AGOURA HILLS STATE: CA ZIP: 91301 4 1 wk-form4_1704409733.xml FORM 4 X0508 4 2024-01-02 0 0001962918 ACELYRIN, Inc. SLRN 0001725092 Lin Shao-Lee C/O ACELYRIN, INC. 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301 1 1 0 0 Chief Executive Officer 0 Common Stock 2024-01-02 4 S 0 10691 7.407 D 1603036 D Common Stock 487205 I See footnote Common Stock 677813 I See footnote Common Stock 354969 I See footnote Common Stock 349898 I See footnote Common Stock 5070 I See footnote The sale reported on this Form 4 was effected pursuant to the Issuer's policy requiring sell-to-cover to satisfy certain tax obligations of the Reporting Person incurred with the vesting and settlement of certain Restricted Stock Units, and does not represent a discretionary sale by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices no more than $7.62 and no less than $7.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Includes 1,293 shares of Common Stock acquired pursuant to the Issuer's 2023 Employee Stock Purchase Plan ("ESPP"), for the purchase period of June 15, 2023 to December 14, 2023. This transaction is exempt from Rule 16b-3(c). In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's Common Stock on December 14, 2023. Shares held directly by Shao-Lee Lin 2020 Gift Trust Dtd 7/16/20, for which the Reporting Person's spouse serves as trustee. Shares held directly by Shao-Lee Lin, Trustee of the Shao-Lee Lin Trust u/a/d September 23, 2005, for which the Reporting Person serves as trustee. Shares held directly by Lin Family 2020 Gift Trust Dtd 7/16/20, for which the Reporting Person's spouse shares voting and investment power. Shares held directly by Susie Jun 2020 Gift Trust dtd 7/16/20, for which the Reporting Person serves as trustee. Shares held directly by Susie Jun, Trustee of the Susie Jun Trust U/A/D September 23, 2005, for which the Reporting Person's spouse serves as trustee. /s/ Mina Kim, Attorney-in-fact 2024-01-04